- Home
- WAFD vs PTGX Comparison
WAFD vs PTGX Comparison
Compare WAFD & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFD
- PTGX
- Stock Information
- Founded
- WAFD 1917
- PTGX 2006
- Country
- WAFD United States
- PTGX United States
- Employees
- WAFD N/A
- PTGX N/A
- Industry
- WAFD Major Banks
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- WAFD Finance
- PTGX Health Care
- Exchange
- WAFD Nasdaq
- PTGX Nasdaq
- Market Cap
- WAFD 2.6B
- PTGX 2.3B
- IPO Year
- WAFD N/A
- PTGX 2016
- Fundamental
- Price
- WAFD $29.26
- PTGX $38.75
- Analyst Decision
- WAFD Hold
- PTGX Strong Buy
- Analyst Count
- WAFD 5
- PTGX 8
- Target Price
- WAFD $33.20
- PTGX $57.13
- AVG Volume (30 Days)
- WAFD 394.3K
- PTGX 509.7K
- Earning Date
- WAFD 01-16-2025
- PTGX 02-21-2025
- Dividend Yield
- WAFD 3.70%
- PTGX N/A
- EPS Growth
- WAFD N/A
- PTGX N/A
- EPS
- WAFD 2.22
- PTGX 4.23
- Revenue
- WAFD $708,753,000.00
- PTGX $434,433,000.00
- Revenue This Year
- WAFD N/A
- PTGX $445.33
- Revenue Next Year
- WAFD $9.68
- PTGX N/A
- P/E Ratio
- WAFD $13.15
- PTGX $9.20
- Revenue Growth
- WAFD 5.31
- PTGX 624.05
- 52 Week Low
- WAFD $25.79
- PTGX $24.22
- 52 Week High
- WAFD $38.62
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- WAFD 39.72
- PTGX 52.47
- Support Level
- WAFD $29.30
- PTGX $37.50
- Resistance Level
- WAFD $30.45
- PTGX $39.37
- Average True Range (ATR)
- WAFD 0.83
- PTGX 1.32
- MACD
- WAFD 0.08
- PTGX 0.16
- Stochastic Oscillator
- WAFD 25.47
- PTGX 67.70
About WAFD WaFd Inc.
WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.